Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Moodys
Farmers Insurance
Mallinckrodt
QuintilesIMS
Express Scripts
Deloitte
Cantor Fitzgerald

Generated: October 20, 2018

DrugPatentWatch Database Preview

Flutemetamol f-18 - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for flutemetamol f-18 and what is the scope of flutemetamol f-18 freedom to operate?

Flutemetamol f-18 is the generic ingredient in one branded drug marketed by Ge Healthcare and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

One supplier is listed for this compound.

Summary for flutemetamol f-18
US Patents:5
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 1
Clinical Trials: 18
Patent Applications: 14
DailyMed Link:flutemetamol f-18 at DailyMed
Pharmacology for flutemetamol f-18
Synonyms for flutemetamol f-18
((18 sup)F)AH110690
[18F]-Flutemetamol
[18F]-Flutemetamol F18
[18F]AH110690
[18F]flutemetamol
18F-Flutemetamol
2-(3-((18 sup)F)Fluoro-4-(methylamino)phenyl)-1,3-benzothiazol-6-ol
2-(3-(sup 18)f)Fluoro-4-(methylamino)phenyl)-1,3-benzothiazol-6-ol
2-[3-((18)F)fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol
2-[3-(18F)fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol
6-Benzothiazolol, 2-(3-(fluoro-(sup 18)F)-4-(methylamino)phenyl)-
765922-62-1
CHEBI:76611
CHEMBL2042122
D10231
DB09151
DTXSID80227394
Flutemetamol
flutemetamol ((18)F)
Flutemetamol ((sup 18)F)
Flutemetamol ((sup18)F)
flutemetamol (18F)
Flutemetamol (18F) [INN]
Flutemetamol F 18
Flutemetamol F 18 (USAN)
Flutemetamol F 18 [USAN]
flutemetamol F 18 injection
Flutemetamol F18
GTPL7342
L49M066S0O
SCHEMBL10032147
UNII-L49M066S0O
Vizamyl
Vizamyl (TN)

US Patents and Regulatory Information for flutemetamol f-18

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare VIZAMYL flutemetamol f-18 INJECTABLE;INTRAVENOUS 203137-002 Oct 25, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ge Healthcare VIZAMYL flutemetamol f-18 INJECTABLE;INTRAVENOUS 203137-002 Oct 25, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Ge Healthcare VIZAMYL flutemetamol f-18 INJECTABLE;INTRAVENOUS 203137-002 Oct 25, 2013 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Ge Healthcare VIZAMYL flutemetamol f-18 INJECTABLE;INTRAVENOUS 203137-001 Oct 25, 2013 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for flutemetamol f-18

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015 Austria ➤ Try a Free Trial PRODUCT NAME: (18F) - FLUTEMETAMOL; REGISTRATION NO/DATE: EU/1/14/941 (MITTEILUNG) 20140826
90009-5 Sweden ➤ Try a Free Trial PRODUCT NAME: FLUTEMETAMOL (18F); REG. NO/DATE: EU/1/14/941 20140826
C0006 France ➤ Try a Free Trial PRODUCT NAME: FLUTEMETAMOL (18 F); REGISTRATION NO/DATE: EU/1/14/941 20140822
3 5003-2015 Slovakia ➤ Try a Free Trial PRODUCT NAME: FLUTEMETAMOL (18F); REGISTRATION NO/DATE: EU/1/14/941 20140822
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Moodys
Farmers Insurance
Mallinckrodt
QuintilesIMS
Express Scripts
Deloitte
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.